Future Challenges in Prostate Magnetic Resonance Imaging Prostat Manyetik Rezonans Görüntülemede Gelecekteki Beklentiler

Creative Commons License

Ayyıldız H., Ersoy B., Tunacı A., Ertürk Ş. M.

Medical Journal of Bakirkoy, cilt.22, sa.3, ss.204-212, 2026 (ESCI, Scopus, TRDizin)

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 22 Sayı: 3
  • Basım Tarihi: 2026
  • Doi Numarası: 10.4274/bmj.galenos.2025.2025.1-17
  • Dergi Adı: Medical Journal of Bakirkoy
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, CINAHL, EMBASE, TR DİZİN (ULAKBİM), Academic Search Ultimate (EBSCO), Biomedical Reference Collection: Corporate Edition (EBSCO), Health Research Premium Collection (ProQuest), Pharma Collection (ProQuest)
  • Sayfa Sayıları: ss.204-212
  • Anahtar Kelimeler: bi-parametric MRI, computed DWI, MR spectroscopy, multiparametric MRI, PI-RADS, Prostate cancer, radiomics
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • İstanbul Üniversitesi Adresli: Evet

Özet

Prostate cancer poses a significant healthcare challenge. Multiparametric prostate magnetic resonance imaging (mpMRI) has emerged as a valuable diagnostic tool, combining anatomical and functional sequences for enhanced accuracy. Advances in mpMRI techniques, including biparametric MRI and radiomics, offer promising improvements for prostate cancer detection and management. Prostate cancer is a major cause of morbidity and mortality. Despite the widespread use of the prostate-specific antigen test for screening, its limitations include overdiagnosis. mpMRI, which integrates anatomical and functional sequences, has demonstrated improved diagnostic accuracy, particularly after updates to prostate imaging reporting and data system (PI-RADS). New techniques such as bi-parametric MRI and computed diffusion weighted imaging are increasingly important, spurring research into MRI-based prostate cancer screening. Efforts to shorten MRI acquisition time have led to the development of short-MRI protocols and quality scores, such as PI-quality. Radiomics has also gained importance in prostate imaging. This article explores these advancements and future prospects in prostate MRI. MpMRI’s role in prostate cancer diagnosis is expanding. This article discusses the future potential of spectroscopy, innovations in PI-RADS, new MRI protocols and MRI’s role in screening and the challenges and solutions for widespread MRI use.